Bipolar Rise in Kids Drives Debate

A bipolar disorder diagnosis may not only stigmatize a child, but also lead to harms from medications, feeling set apart from other kids and having future hopes dashed.

Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 mg/day For The Treatment Of ...

Pfizer Inc. announced new data presented at the 165th Annual Meeting of the American Psychiatric Association in Philadelphia on PRISTIQ® Extended Release Tablets 50 mg/day for the treatment of major depressive disorder in adults,1 including a long-term relapse prevention study.